MASI has been the subject of a number of other research reports. Needham & Company LLC lifted their price objective on Masimo from $163.00 to $179.00 and gave the company a buy rating in a research note on Wednesday, August 10th. Piper Sandler lifted their price objective on Masimo from $130.00 to $135.00 and gave the company a neutral rating in a research note on Wednesday, August 10th. StockNews.com cut Masimo from a buy rating to a hold rating in a research note on Wednesday, August 10th. Finally, Stifel Nicolaus boosted their price target on Masimo from $162.00 to $172.00 and gave the stock a buy rating in a research note on Monday. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $188.20.
Masimo Trading Down 6.5 %
NASDAQ MASI opened at $146.37 on Tuesday. The company has a quick ratio of 1.28, a current ratio of 2.10 and a debt-to-equity ratio of 0.77. Masimo has a twelve month low of $112.07 and a twelve month high of $305.21. The firm has a market capitalization of $7.69 billion, a PE ratio of 44.09 and a beta of 0.96. The stock’s 50 day moving average is $146.33 and its 200 day moving average is $141.20.
Institutional Trading of Masimo
Hedge funds have recently bought and sold shares of the company. Center for Financial Planning Inc. purchased a new stake in Masimo during the first quarter valued at $29,000. Meeder Asset Management Inc. increased its position in Masimo by 61.3% during the second quarter. Meeder Asset Management Inc. now owns 221 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 84 shares during the last quarter. Itau Unibanco Holding S.A. purchased a new stake in Masimo during the fourth quarter valued at $80,000. Parallel Advisors LLC increased its position in Masimo by 38.8% during the second quarter. Parallel Advisors LLC now owns 365 shares of the medical equipment provider’s stock valued at $48,000 after acquiring an additional 102 shares during the last quarter. Finally, Archer Investment Corp grew its holdings in Masimo by 62.2% during the second quarter. Archer Investment Corp now owns 391 shares of the medical equipment provider’s stock valued at $51,000 after purchasing an additional 150 shares during the period. Hedge funds and other institutional investors own 93.31% of the company’s stock.
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
- Get a free copy of the StockNews.com research report on Masimo (MASI)
- Is Five Below Trying to Punch Too High?
- These 3 Reports Will Tell Us Much About the Current Economy
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle’s FQ1 Report
- Three Value Stocks For A Volatile Market
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.